Roumell Cuts Exposure to Transcept Pharmaceuticals (TSPT) and Ups Stake in DSP Group (DSPG)

Jim Roumell’s Roumell Asset Management, filed yesterday, two forms disclosing its current positions in Transcept Pharmaceuticals Inc (NASDAQ:TSPT) and DSP Group, Inc. (NASDAQ:DSPG).

In relation to DSP Group, Inc. (NASDAQ:DSPG), Roumell reported an increase in its ownership, to a current amount of 1.06 million shares, from 984,200 shares declared in its last 13F filing. The fund’s holdings in the company are valued at more than $9 million.

DSP Group is a micro-cap (less than $200 million market cap) company that provides system solutions that combine semiconductors and software with reference designs. Despite its razor thin margins and returns, and poor EPS growth projections, its stock trades at 88.5 times the company´s earnings, but only at 1.3 times its sales. However, its valuation does not seem justified. Notwithstanding, Roumell has been upping its stakes in DSP Group, Inc. (NASDAQ:DSPG) for several months now.

Jim Roumell

Other funds betting on DSP Group are D E Shaw, which last reported having increased its stakes by 7% over Q3, to 81,300 shares. On the contrary, the three remaining funds among the top 5 bulls in DSP Group, Inc. (NASDAQ:DSPG), Starboard Value Lp, Nokomis Capital and Renaissance Technologies all reduced their holdings over 2013’s third quarter.

On the other hand, Roumell Asset Management declared trimming its position in Transcept Pharmaceuticals Inc (NASDAQ:TSPT), currently holding 2.20 million shares, Roumell reduced its participation in the company by about 2%, in relation to its last 13F filing, for 2013′s Q3. The stake held by Roumell now amasses around 11.7% of the outstanding stock. Earlier, the fund acknowledged selling 48,200 shares of the company. Then, on Dec. 31st, it sold another 59,600 shares.

These moves are quite understandable, given Transcept Pharmaceuticals Inc (NASDAQ:TSPT)’s negative margins and returns and awful growth projections. In fact, most analysts seem to agree on the idea that Transcept is clearly a “hold” case, for now. However, other hedge fund managers like Jim Simons, D. E. Shaw, Cliff Asness and Paul Touradji do not seem to agree with this view, as all of them last reported having added this company´s stock to their equity portfolios (and we are talking about, at least, 10,000 shares each).

Disclosure: Javier Hasse holds no position in any stocks mentioned

Recommended Reading:

Baupost Group Buys Over 16 Mln Shares of Idenix Pharmaceuticals Inc (IDIX)

Ra Capital Management Initiates Stake in Furiex Pharmaceuticals Inc (FURX) After the Stock Jumped

Deerfield Management Discloses Stake in Post-IPO Auspex Pharmaceuticals Inc (ASPX)

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Best Countries To Work In the World

A Profitable Day At The Track: 5 Tips For Betting On Horses

Tearing You Apart: 6 Bad Habits That Ruin Relationships

Learning on the Job: The 6 Biggest Mistakes Parents Make

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Burger Kings: The 10 Most Expensive Burgers in the World

The 10 Most Ethnically Diverse Countries in the World

The 10 Most Exclusive Credit Cards in the World

The 10 Most Expensive Cruise Ships in the World

The 10 Fastest Supercomputers in the World

The 10 Best Countries for Doing Business 2015

6 Most Expensive Fruits In The World

10 Worst Airlines in the World

The 10 Biggest Tax Havens in the World to Stash Your Money

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!